nodes	percent_of_prediction	percent_of_DWPC	metapath
Mometasone—NR3C1—type 2 diabetes mellitus	0.395	1	CbGaD
Mometasone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0863	0.213	CbGbCtD
Mometasone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.069	0.17	CbGbCtD
Mometasone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0624	0.154	CbGbCtD
Mometasone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0576	0.142	CbGbCtD
Mometasone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0556	0.137	CbGbCtD
Mometasone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0453	0.112	CbGbCtD
Mometasone—CYP2C8—Losartan—type 2 diabetes mellitus	0.0292	0.0721	CbGbCtD
Mometasone—Prednisone—HSD11B1—type 2 diabetes mellitus	0.00057	0.099	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000293	0.00675	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—HNF1A—type 2 diabetes mellitus	0.000288	0.00664	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—type 2 diabetes mellitus	0.000269	0.0062	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—MIF—type 2 diabetes mellitus	0.000266	0.00613	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—AR—type 2 diabetes mellitus	0.000261	0.00601	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HNF4A—type 2 diabetes mellitus	0.00026	0.00599	CbGpPWpGaD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—PPARA—type 2 diabetes mellitus	0.000256	0.00589	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—AR—type 2 diabetes mellitus	0.000253	0.00583	CbGpPWpGaD
Mometasone—NR3C1—Nuclear Receptors—PPARA—type 2 diabetes mellitus	0.00025	0.00576	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TIMP1—type 2 diabetes mellitus	0.000242	0.00558	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—PCK1—type 2 diabetes mellitus	0.000242	0.00556	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—PPARGC1A—type 2 diabetes mellitus	0.000232	0.00533	CbGpPWpGaD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SIRT1—type 2 diabetes mellitus	0.000231	0.00531	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—AVP—type 2 diabetes mellitus	0.000228	0.00526	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—TCF7L2—type 2 diabetes mellitus	0.000225	0.00519	CbGpPWpGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—type 2 diabetes mellitus	0.000209	0.00481	CbGpPWpGaD
Mometasone—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00138	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptors—PPARG—type 2 diabetes mellitus	0.000207	0.00476	CbGpPWpGaD
Mometasone—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000206	0.00137	CcSEcCtD
Mometasone—Back pain—Orlistat—type 2 diabetes mellitus	0.000205	0.00136	CcSEcCtD
Mometasone—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00136	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—GJA1—type 2 diabetes mellitus	0.000204	0.0047	CbGpPWpGaD
Mometasone—Cough—Gliclazide—type 2 diabetes mellitus	0.000204	0.00136	CcSEcCtD
Mometasone—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Mometasone—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000203	0.00135	CcSEcCtD
Mometasone—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000203	0.00135	CcSEcCtD
Mometasone—Anorexia—Glyburide—type 2 diabetes mellitus	0.000203	0.00135	CcSEcCtD
Mometasone—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000203	0.00135	CcSEcCtD
Mometasone—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000202	0.00134	CcSEcCtD
Mometasone—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000201	0.00133	CcSEcCtD
Mometasone—Rhinitis—Losartan—type 2 diabetes mellitus	0.0002	0.00133	CcSEcCtD
Mometasone—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000199	0.00132	CcSEcCtD
Mometasone—Nausea—Repaglinide—type 2 diabetes mellitus	0.000198	0.00132	CcSEcCtD
Mometasone—Asthenia—Glipizide—type 2 diabetes mellitus	0.000198	0.00132	CcSEcCtD
Mometasone—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000198	0.00132	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARA—type 2 diabetes mellitus	0.000198	0.00455	CbGpPWpGaD
Mometasone—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000197	0.00455	CbGpPWpGaD
Mometasone—Angioedema—Valsartan—type 2 diabetes mellitus	0.000196	0.0013	CcSEcCtD
Mometasone—Pruritus—Glipizide—type 2 diabetes mellitus	0.000196	0.0013	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000195	0.00449	CbGpPWpGaD
Mometasone—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Mometasone—Angioedema—Orlistat—type 2 diabetes mellitus	0.000194	0.00129	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000194	0.00129	CcSEcCtD
Mometasone—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.00127	CcSEcCtD
Mometasone—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000191	0.00127	CcSEcCtD
Mometasone—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000191	0.00127	CcSEcCtD
Mometasone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—type 2 diabetes mellitus	0.00019	0.00438	CbGpPWpGaD
Mometasone—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Mometasone—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Mometasone—Infection—Gliclazide—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Mometasone—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.00019	0.00126	CcSEcCtD
Mometasone—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000189	0.00126	CcSEcCtD
Mometasone—Cough—Valsartan—type 2 diabetes mellitus	0.000188	0.00125	CcSEcCtD
Mometasone—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000187	0.00125	CcSEcCtD
Mometasone—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000187	0.00124	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—CYP1A2—type 2 diabetes mellitus	0.000186	0.00429	CbGpPWpGaD
Mometasone—NR3C1—Circadian Clock—PPARA—type 2 diabetes mellitus	0.000186	0.00429	CbGpPWpGaD
Mometasone—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Mometasone—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Mometasone—Cough—Orlistat—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Mometasone—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Mometasone—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000185	0.00123	CcSEcCtD
Mometasone—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Mometasone—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Mometasone—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Mometasone—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000183	0.00122	CcSEcCtD
Mometasone—Chest pain—Valsartan—type 2 diabetes mellitus	0.000183	0.00122	CcSEcCtD
Mometasone—Myalgia—Valsartan—type 2 diabetes mellitus	0.000183	0.00122	CcSEcCtD
Mometasone—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000182	0.00121	CcSEcCtD
Mometasone—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—HIF1A—type 2 diabetes mellitus	0.000181	0.00417	CbGpPWpGaD
Mometasone—Chest pain—Orlistat—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Mometasone—Myalgia—Orlistat—type 2 diabetes mellitus	0.000181	0.0012	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—type 2 diabetes mellitus	0.00018	0.00416	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—type 2 diabetes mellitus	0.00018	0.00415	CbGpPWpGaD
Mometasone—Epistaxis—Ramipril—type 2 diabetes mellitus	0.00018	0.0012	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—EDN1—type 2 diabetes mellitus	0.000179	0.00413	CbGpPWpGaD
Mometasone—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Mometasone—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000179	0.00119	CcSEcCtD
Mometasone—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Mometasone—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000176	0.00117	CcSEcCtD
Mometasone—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000176	0.00117	CcSEcCtD
Mometasone—Vomiting—Glipizide—type 2 diabetes mellitus	0.000176	0.00117	CcSEcCtD
Mometasone—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000176	0.0305	CrCbGaD
Mometasone—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000175	0.00117	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—NAMPT—type 2 diabetes mellitus	0.000175	0.00402	CbGpPWpGaD
Mometasone—Infection—Valsartan—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Mometasone—Rash—Glipizide—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Mometasone—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Mometasone—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000174	0.00116	CcSEcCtD
Mometasone—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Mometasone—Headache—Glipizide—type 2 diabetes mellitus	0.000173	0.00115	CcSEcCtD
Mometasone—CYP2C8—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000173	0.00398	CbGpPWpGaD
Mometasone—Infection—Orlistat—type 2 diabetes mellitus	0.000172	0.00114	CcSEcCtD
Mometasone—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000171	0.00114	CcSEcCtD
Mometasone—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.00017	0.00113	CcSEcCtD
Mometasone—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.00017	0.0295	CrCbGaD
Mometasone—Clocortolone—NR3C1—type 2 diabetes mellitus	0.00017	0.0295	CrCbGaD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—TNF—type 2 diabetes mellitus	0.00017	0.00392	CbGpPWpGaD
Mometasone—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000169	0.00112	CcSEcCtD
Mometasone—Back pain—Losartan—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Mometasone—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Mometasone—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000168	0.00112	CcSEcCtD
Mometasone—Anorexia—Valsartan—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Mometasone—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Mometasone—Myalgia—Metformin—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Mometasone—Chest pain—Metformin—type 2 diabetes mellitus	0.000167	0.00111	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—type 2 diabetes mellitus	0.000166	0.00383	CbGpPWpGaD
Mometasone—Headache—Pioglitazone—type 2 diabetes mellitus	0.000166	0.0011	CcSEcCtD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—type 2 diabetes mellitus	0.000165	0.00381	CbGpPWpGaD
Mometasone—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Mometasone—Nausea—Glipizide—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Mometasone—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000164	0.00109	CcSEcCtD
Mometasone—NR3C1—Nuclear Receptor transcription pathway—PPARG—type 2 diabetes mellitus	0.000164	0.00376	CbGpPWpGaD
Mometasone—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000163	0.00109	CcSEcCtD
Mometasone—Pain—Gliclazide—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	0.000163	0.00375	CbGpPWpGaD
Mometasone—Rash—Glimepiride—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Mometasone—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000162	0.00108	CcSEcCtD
Mometasone—Rash—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00108	CcSEcCtD
Mometasone—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000162	0.00108	CcSEcCtD
Mometasone—Headache—Glimepiride—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Mometasone—Cough—Irbesartan—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	0.000161	0.00371	CbGpPWpGaD
Mometasone—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000161	0.028	CrCbGaD
Mometasone—Desonide—NR3C1—type 2 diabetes mellitus	0.000161	0.028	CrCbGaD
Mometasone—Headache—Sitagliptin—type 2 diabetes mellitus	0.000161	0.00107	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	0.000161	0.0037	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	0.00016	0.00369	CbGpPWpGaD
Mometasone—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00016	0.00106	CcSEcCtD
Mometasone—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000159	0.00106	CcSEcCtD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	0.000159	0.00366	CbGpPWpGaD
Mometasone—Angioedema—Losartan—type 2 diabetes mellitus	0.000159	0.00106	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—HMGA1—type 2 diabetes mellitus	0.000159	0.00366	CbGpPWpGaD
Mometasone—Infection—Metformin—type 2 diabetes mellitus	0.000159	0.00105	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Mometasone—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000158	0.00105	CcSEcCtD
Mometasone—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Mometasone—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Mometasone—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000157	0.00104	CcSEcCtD
Mometasone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—type 2 diabetes mellitus	0.000157	0.00362	CbGpPWpGaD
Mometasone—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000157	0.0273	CrCbGaD
Mometasone—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000156	0.00104	CcSEcCtD
Mometasone—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000156	0.00104	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—SREBF1—type 2 diabetes mellitus	0.000156	0.00358	CbGpPWpGaD
Mometasone—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Mometasone—Loteprednol—NR3C1—type 2 diabetes mellitus	0.000155	0.0269	CrCbGaD
Mometasone—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—type 2 diabetes mellitus	0.000155	0.00357	CbGpPWpGaD
Mometasone—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.00103	CcSEcCtD
Mometasone—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000154	0.00103	CcSEcCtD
Mometasone—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.00103	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000154	0.00354	CbGpPWpGaD
Mometasone—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000154	0.00102	CcSEcCtD
Mometasone—Nausea—Glimepiride—type 2 diabetes mellitus	0.000153	0.00102	CcSEcCtD
Mometasone—Fludrocortisone—AR—type 2 diabetes mellitus	0.000153	0.0266	CrCbGaD
Mometasone—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Mometasone—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Mometasone—Asthenia—Glyburide—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Mometasone—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Mometasone—Anorexia—Metformin—type 2 diabetes mellitus	0.000152	0.00101	CcSEcCtD
Mometasone—Cough—Losartan—type 2 diabetes mellitus	0.000152	0.00101	CcSEcCtD
Mometasone—Fatigue—Valsartan—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Mometasone—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Mometasone—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Mometasone—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Mometasone—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000151	0.001	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—MMP1—type 2 diabetes mellitus	0.000151	0.00347	CbGpPWpGaD
Mometasone—Pruritus—Glyburide—type 2 diabetes mellitus	0.00015	0.000999	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.00015	0.00345	CbGpPWpGaD
Mometasone—Infection—Irbesartan—type 2 diabetes mellitus	0.00015	0.000995	CcSEcCtD
Mometasone—Fatigue—Orlistat—type 2 diabetes mellitus	0.000149	0.000993	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—HIF1A—type 2 diabetes mellitus	0.000149	0.00344	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—AGT—type 2 diabetes mellitus	0.000149	0.00342	CbGpPWpGaD
Mometasone—Pain—Orlistat—type 2 diabetes mellitus	0.000148	0.000985	CcSEcCtD
Mometasone—Arthralgia—Losartan—type 2 diabetes mellitus	0.000148	0.000983	CcSEcCtD
Mometasone—Myalgia—Losartan—type 2 diabetes mellitus	0.000148	0.000983	CcSEcCtD
Mometasone—Chest pain—Losartan—type 2 diabetes mellitus	0.000148	0.000983	CcSEcCtD
Mometasone—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000148	0.000982	CcSEcCtD
Mometasone—Rash—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000974	CcSEcCtD
Mometasone—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000147	0.000973	CcSEcCtD
Mometasone—Headache—Bromocriptine—type 2 diabetes mellitus	0.000146	0.000968	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000146	0.000967	CcSEcCtD
Mometasone—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000146	0.000966	CcSEcCtD
Mometasone—Dry mouth—Losartan—type 2 diabetes mellitus	0.000145	0.000961	CcSEcCtD
Mometasone—Fluoxymesterone—SHBG—type 2 diabetes mellitus	0.000144	0.025	CrCbGaD
Mometasone—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000144	0.000955	CcSEcCtD
Mometasone—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000143	0.000953	CcSEcCtD
Mometasone—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000143	0.000953	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—ADIPOQ—type 2 diabetes mellitus	0.000143	0.00329	CbGpPWpGaD
Mometasone—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000142	0.000946	CcSEcCtD
Mometasone—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000142	0.000942	CcSEcCtD
Mometasone—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000142	0.000942	CcSEcCtD
Mometasone—Infection—Losartan—type 2 diabetes mellitus	0.000141	0.000936	CcSEcCtD
Mometasone—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000141	0.000934	CcSEcCtD
Mometasone—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000139	0.000922	CcSEcCtD
Mometasone—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000139	0.000921	CcSEcCtD
Mometasone—NR3C1—Circadian Clock—SERPINE1—type 2 diabetes mellitus	0.000139	0.00319	CbGpPWpGaD
Mometasone—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000138	0.000918	CcSEcCtD
Mometasone—Fatigue—Metformin—type 2 diabetes mellitus	0.000138	0.000915	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000137	0.000912	CcSEcCtD
Mometasone—NR3C1—Transcription factor regulation in adipogenesis—IL6—type 2 diabetes mellitus	0.000137	0.00316	CbGpPWpGaD
Mometasone—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000137	0.00091	CcSEcCtD
Mometasone—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000137	0.00091	CcSEcCtD
Mometasone—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000137	0.00091	CcSEcCtD
Mometasone—CYP2C8—Arachidonic acid metabolism—GPX1—type 2 diabetes mellitus	0.000137	0.00315	CbGpPWpGaD
Mometasone—Angioedema—Ramipril—type 2 diabetes mellitus	0.000136	0.000905	CcSEcCtD
Mometasone—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000135	0.000899	CcSEcCtD
Mometasone—Anorexia—Losartan—type 2 diabetes mellitus	0.000135	0.000898	CcSEcCtD
Mometasone—Vomiting—Glyburide—type 2 diabetes mellitus	0.000135	0.000898	CcSEcCtD
Mometasone—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000135	0.0235	CrCbGaD
Mometasone—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000135	0.000897	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—SLC2A4—type 2 diabetes mellitus	0.000135	0.00311	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000135	0.0031	CbGpPWpGaD
Mometasone—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000893	CcSEcCtD
Mometasone—Rash—Glyburide—type 2 diabetes mellitus	0.000134	0.000891	CcSEcCtD
Mometasone—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000134	0.00089	CcSEcCtD
Mometasone—Headache—Glyburide—type 2 diabetes mellitus	0.000133	0.000885	CcSEcCtD
Mometasone—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000133	0.0231	CrCbGaD
Mometasone—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000133	0.000882	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—type 2 diabetes mellitus	0.000133	0.00305	CbGpPWpGaD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	0.000132	0.00304	CbGpPWpGaD
Mometasone—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000131	0.000871	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	0.000131	0.00301	CbGpPWpGaD
Mometasone—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000131	0.000868	CcSEcCtD
Mometasone—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000131	0.000868	CcSEcCtD
Mometasone—Cough—Ramipril—type 2 diabetes mellitus	0.00013	0.000864	CcSEcCtD
Mometasone—Fatigue—Irbesartan—type 2 diabetes mellitus	0.00013	0.000863	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000129	0.000859	CcSEcCtD
Mometasone—Pain—Irbesartan—type 2 diabetes mellitus	0.000129	0.000856	CcSEcCtD
Mometasone—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—type 2 diabetes mellitus	0.000127	0.00293	CbGpPWpGaD
Mometasone—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000127	0.000846	CcSEcCtD
Mometasone—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000127	0.000843	CcSEcCtD
Mometasone—Chest pain—Ramipril—type 2 diabetes mellitus	0.000127	0.000843	CcSEcCtD
Mometasone—Myalgia—Ramipril—type 2 diabetes mellitus	0.000127	0.000843	CcSEcCtD
Mometasone—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000127	0.00084	CcSEcCtD
Mometasone—Fluoxymesterone—AR—type 2 diabetes mellitus	0.000126	0.0219	CrCbGaD
Mometasone—Nausea—Glyburide—type 2 diabetes mellitus	0.000126	0.000839	CcSEcCtD
Mometasone—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000126	0.000839	CcSEcCtD
Mometasone—Asthenia—Valsartan—type 2 diabetes mellitus	0.000126	0.000836	CcSEcCtD
Mometasone—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000125	0.00083	CcSEcCtD
Mometasone—Asthenia—Orlistat—type 2 diabetes mellitus	0.000124	0.000826	CcSEcCtD
Mometasone—Pruritus—Valsartan—type 2 diabetes mellitus	0.000124	0.000824	CcSEcCtD
Mometasone—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000124	0.000824	CcSEcCtD
Mometasone—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000124	0.0215	CrCbGaD
Mometasone—Budesonide—NR3C1—type 2 diabetes mellitus	0.000124	0.0215	CrCbGaD
Mometasone—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000123	0.000819	CcSEcCtD
Mometasone—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000123	0.000819	CcSEcCtD
Mometasone—Pruritus—Orlistat—type 2 diabetes mellitus	0.000123	0.000815	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CCL2—type 2 diabetes mellitus	0.000122	0.00282	CbGpPWpGaD
Mometasone—Fatigue—Losartan—type 2 diabetes mellitus	0.000122	0.000813	CcSEcCtD
Mometasone—NR3C1—Gene Expression—IGF2BP2—type 2 diabetes mellitus	0.000122	0.00281	CbGpPWpGaD
Mometasone—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000122	0.000808	CcSEcCtD
Mometasone—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000121	0.000806	CcSEcCtD
Mometasone—Pain—Losartan—type 2 diabetes mellitus	0.000121	0.000806	CcSEcCtD
Mometasone—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000121	0.0211	CrCbGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—type 2 diabetes mellitus	0.000121	0.00278	CbGpPWpGaD
Mometasone—Rash—Gliclazide—type 2 diabetes mellitus	0.00012	0.0008	CcSEcCtD
Mometasone—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00012	0.000799	CcSEcCtD
Mometasone—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.00012	0.000797	CcSEcCtD
Mometasone—Headache—Gliclazide—type 2 diabetes mellitus	0.00012	0.000795	CcSEcCtD
Mometasone—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000119	0.000792	CcSEcCtD
Mometasone—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000119	0.000792	CcSEcCtD
Mometasone—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000119	0.000788	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—PPARGC1A—type 2 diabetes mellitus	0.000116	0.00268	CbGpPWpGaD
Mometasone—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000116	0.0202	CrCbGaD
Mometasone—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000116	0.000771	CcSEcCtD
Mometasone—Anorexia—Ramipril—type 2 diabetes mellitus	0.000116	0.00077	CcSEcCtD
Mometasone—Asthenia—Metformin—type 2 diabetes mellitus	0.000115	0.000761	CcSEcCtD
Mometasone—Nausea—Gliclazide—type 2 diabetes mellitus	0.000113	0.000753	CcSEcCtD
Mometasone—Pruritus—Metformin—type 2 diabetes mellitus	0.000113	0.000751	CcSEcCtD
Mometasone—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000112	0.000745	CcSEcCtD
Mometasone—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000112	0.000745	CcSEcCtD
Mometasone—Vomiting—Valsartan—type 2 diabetes mellitus	0.000112	0.000741	CcSEcCtD
Mometasone—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000111	0.000736	CcSEcCtD
Mometasone—Rash—Valsartan—type 2 diabetes mellitus	0.000111	0.000735	CcSEcCtD
Mometasone—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000111	0.000734	CcSEcCtD
Mometasone—Vomiting—Orlistat—type 2 diabetes mellitus	0.00011	0.000732	CcSEcCtD
Mometasone—Headache—Valsartan—type 2 diabetes mellitus	0.00011	0.00073	CcSEcCtD
Mometasone—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.00011	0.019	CrCbGaD
Mometasone—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.00011	0.019	CrCbGaD
Mometasone—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000109	0.000726	CcSEcCtD
Mometasone—Rash—Orlistat—type 2 diabetes mellitus	0.000109	0.000726	CcSEcCtD
Mometasone—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000109	0.000726	CcSEcCtD
Mometasone—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000109	0.000725	CcSEcCtD
Mometasone—Headache—Orlistat—type 2 diabetes mellitus	0.000109	0.000721	CcSEcCtD
Mometasone—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000108	0.00072	CcSEcCtD
Mometasone—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000718	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000108	0.00248	CbGpPWpGaD
Mometasone—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000107	0.000711	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—CDKN2A—type 2 diabetes mellitus	0.000107	0.00246	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000107	0.00246	CbGpPWpGaD
Mometasone—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000107	0.000708	CcSEcCtD
Mometasone—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000107	0.0185	CrCbGaD
Mometasone—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000107	0.0185	CrCbGaD
Mometasone—NR3C1—Adipogenesis—LPL—type 2 diabetes mellitus	0.000106	0.00244	CbGpPWpGaD
Mometasone—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000106	0.000702	CcSEcCtD
Mometasone—Fatigue—Ramipril—type 2 diabetes mellitus	0.000105	0.000697	CcSEcCtD
Mometasone—Nausea—Valsartan—type 2 diabetes mellitus	0.000104	0.000692	CcSEcCtD
Mometasone—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.000104	0.018	CrCbGaD
Mometasone—Fludrocortisone—NR3C1—type 2 diabetes mellitus	0.000104	0.018	CrCbGaD
Mometasone—Flunisolide—NR3C1—type 2 diabetes mellitus	0.000104	0.018	CrCbGaD
Mometasone—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000103	0.000685	CcSEcCtD
Mometasone—Nausea—Orlistat—type 2 diabetes mellitus	0.000103	0.000684	CcSEcCtD
Mometasone—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000102	0.0178	CrCbGaD
Mometasone—Asthenia—Losartan—type 2 diabetes mellitus	0.000102	0.000676	CcSEcCtD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—type 2 diabetes mellitus	0.000102	0.00234	CbGpPWpGaD
Mometasone—Vomiting—Metformin—type 2 diabetes mellitus	0.000102	0.000675	CcSEcCtD
Mometasone—NR3C1—Regulation of Androgen receptor activity—SRC—type 2 diabetes mellitus	0.000101	0.00232	CbGpPWpGaD
Mometasone—Rash—Metformin—type 2 diabetes mellitus	0.000101	0.000669	CcSEcCtD
Mometasone—Dermatitis—Metformin—type 2 diabetes mellitus	0.000101	0.000668	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000101	0.00232	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000101	0.00232	CbGpPWpGaD
Mometasone—Pruritus—Losartan—type 2 diabetes mellitus	0.0001	0.000667	CcSEcCtD
Mometasone—Headache—Metformin—type 2 diabetes mellitus	0.0001	0.000665	CcSEcCtD
Mometasone—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.0001	0.0174	CrCbGaD
Mometasone—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	9.95e-05	0.000661	CcSEcCtD
Mometasone—NR3C1—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	9.92e-05	0.00228	CbGpPWpGaD
Mometasone—Diarrhoea—Losartan—type 2 diabetes mellitus	9.71e-05	0.000645	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—FAS—type 2 diabetes mellitus	9.67e-05	0.00223	CbGpPWpGaD
Mometasone—Methylprednisolone—NR3C1—type 2 diabetes mellitus	9.67e-05	0.0168	CrCbGaD
Mometasone—Body temperature increased—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000639	CcSEcCtD
Mometasone—Abdominal pain—Ramipril—type 2 diabetes mellitus	9.62e-05	0.000639	CcSEcCtD
Mometasone—Vomiting—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000637	CcSEcCtD
Mometasone—NR3C1—Generic Transcription Pathway—NCOA6—type 2 diabetes mellitus	9.54e-05	0.0022	CbGpPWpGaD
Mometasone—Rash—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000631	CcSEcCtD
Mometasone—Dermatitis—Irbesartan—type 2 diabetes mellitus	9.5e-05	0.000631	CcSEcCtD
Mometasone—Nausea—Metformin—type 2 diabetes mellitus	9.49e-05	0.00063	CcSEcCtD
Mometasone—Headache—Irbesartan—type 2 diabetes mellitus	9.45e-05	0.000627	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—PPARA—type 2 diabetes mellitus	9.36e-05	0.00215	CbGpPWpGaD
Mometasone—Dexamethasone—CYP11A1—type 2 diabetes mellitus	9.27e-05	0.0161	CrCbGaD
Mometasone—NR3C1—Adipogenesis—HIF1A—type 2 diabetes mellitus	9.1e-05	0.00209	CbGpPWpGaD
Mometasone—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	9.09e-05	0.0158	CrCbGaD
Mometasone—NR3C1—Adipogenesis—IRS2—type 2 diabetes mellitus	9.07e-05	0.00209	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—AGT—type 2 diabetes mellitus	9.06e-05	0.00209	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—RELA—type 2 diabetes mellitus	9.05e-05	0.00208	CbGpPWpGaD
Mometasone—Vomiting—Losartan—type 2 diabetes mellitus	9.02e-05	0.000599	CcSEcCtD
Mometasone—Nausea—Irbesartan—type 2 diabetes mellitus	8.96e-05	0.000595	CcSEcCtD
Mometasone—Rash—Losartan—type 2 diabetes mellitus	8.95e-05	0.000594	CcSEcCtD
Mometasone—Dermatitis—Losartan—type 2 diabetes mellitus	8.94e-05	0.000594	CcSEcCtD
Mometasone—Headache—Losartan—type 2 diabetes mellitus	8.89e-05	0.00059	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—LEP—type 2 diabetes mellitus	8.88e-05	0.00204	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—MTR—type 2 diabetes mellitus	8.78e-05	0.00202	CbGpPWpGaD
Mometasone—Hydrocortisone—SHBG—type 2 diabetes mellitus	8.77e-05	0.0152	CrCbGaD
Mometasone—NR3C1—AP-1 transcription factor network—MMP9—type 2 diabetes mellitus	8.76e-05	0.00202	CbGpPWpGaD
Mometasone—Asthenia—Ramipril—type 2 diabetes mellitus	8.73e-05	0.00058	CcSEcCtD
Mometasone—Pruritus—Ramipril—type 2 diabetes mellitus	8.61e-05	0.000572	CcSEcCtD
Mometasone—Fluoxymesterone—NR3C1—type 2 diabetes mellitus	8.57e-05	0.0149	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP11A1—type 2 diabetes mellitus	8.5e-05	0.00196	CbGpPWpGaD
Mometasone—Nausea—Losartan—type 2 diabetes mellitus	8.43e-05	0.00056	CcSEcCtD
Mometasone—CYP2C8—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	8.39e-05	0.00193	CbGpPWpGaD
Mometasone—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.32e-05	0.000553	CcSEcCtD
Mometasone—Triamcinolone—NR3C1—type 2 diabetes mellitus	8.15e-05	0.0142	CrCbGaD
Mometasone—CYP2C8—Arachidonic acid metabolism—PTGS2—type 2 diabetes mellitus	8.06e-05	0.00186	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	7.96e-05	0.00183	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IRS1—type 2 diabetes mellitus	7.92e-05	0.00182	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	7.86e-05	0.00181	CbGpPWpGaD
Mometasone—Vomiting—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000514	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—PPARG—type 2 diabetes mellitus	7.73e-05	0.00178	CbGpPWpGaD
Mometasone—Dexamethasone—NOS2—type 2 diabetes mellitus	7.68e-05	0.0133	CrCbGaD
Mometasone—Rash—Ramipril—type 2 diabetes mellitus	7.67e-05	0.00051	CcSEcCtD
Mometasone—Dermatitis—Ramipril—type 2 diabetes mellitus	7.66e-05	0.000509	CcSEcCtD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—type 2 diabetes mellitus	7.63e-05	0.00176	CbGpPWpGaD
Mometasone—Headache—Ramipril—type 2 diabetes mellitus	7.62e-05	0.000506	CcSEcCtD
Mometasone—NR3C1—Adipogenesis—INS—type 2 diabetes mellitus	7.59e-05	0.00175	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	7.55e-05	0.00174	CbGpPWpGaD
Mometasone—Prednisone—NR3C1—type 2 diabetes mellitus	7.4e-05	0.0128	CrCbGaD
Mometasone—NR3C1—Endoderm Differentiation—TGFB1—type 2 diabetes mellitus	7.39e-05	0.0017	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IGF1—type 2 diabetes mellitus	7.34e-05	0.00169	CbGpPWpGaD
Mometasone—Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	7.29e-05	0.0127	CrCbGaD
Mometasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—type 2 diabetes mellitus	7.27e-05	0.00168	CbGpPWpGaD
Mometasone—Nausea—Ramipril—type 2 diabetes mellitus	7.23e-05	0.00048	CcSEcCtD
Mometasone—NR3C1—AP-1 transcription factor network—TGFB1—type 2 diabetes mellitus	7.22e-05	0.00166	CbGpPWpGaD
Mometasone—Budesonide—CYP3A4—type 2 diabetes mellitus	7.17e-05	0.0124	CrCbGaD
Mometasone—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	7.03e-05	0.0122	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP2E1—type 2 diabetes mellitus	7.02e-05	0.00162	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—SERPINE1—type 2 diabetes mellitus	6.97e-05	0.0016	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—CYP1A2—type 2 diabetes mellitus	6.94e-05	0.0016	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	6.92e-05	0.00159	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	6.85e-05	0.00158	CbGpPWpGaD
Mometasone—Prednisolone—NR3C1—type 2 diabetes mellitus	6.82e-05	0.0118	CrCbGaD
Mometasone—CYP2C8—Biological oxidations—CYP3A4—type 2 diabetes mellitus	6.77e-05	0.00156	CbGpPWpGaD
Mometasone—Betamethasone—NR3C1—type 2 diabetes mellitus	6.68e-05	0.0116	CrCbGaD
Mometasone—CYP2C8—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	6.68e-05	0.00154	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—HNF4A—type 2 diabetes mellitus	6.5e-05	0.0015	CbGpPWpGaD
Mometasone—Alclometasone—CYP3A4—type 2 diabetes mellitus	6.18e-05	0.0107	CrCbGaD
Mometasone—Flunisolide—CYP3A4—type 2 diabetes mellitus	6.02e-05	0.0104	CrCbGaD
Mometasone—Paramethasone—CYP3A4—type 2 diabetes mellitus	5.94e-05	0.0103	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	5.87e-05	0.00135	CbGpPWpGaD
Mometasone—Fluorometholone—CYP3A4—type 2 diabetes mellitus	5.8e-05	0.0101	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	5.72e-05	0.00132	CbGpPWpGaD
Mometasone—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	5.6e-05	0.00973	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—CTGF—type 2 diabetes mellitus	5.58e-05	0.00128	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	5.46e-05	0.00126	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	5.46e-05	0.00126	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	5.46e-05	0.00126	CbGpPWpGaD
Mometasone—NR3C1—AP-1 transcription factor network—IL6—type 2 diabetes mellitus	5.44e-05	0.00125	CbGpPWpGaD
Mometasone—CYP2C8—Biological oxidations—GSTM1—type 2 diabetes mellitus	5.32e-05	0.00122	CbGpPWpGaD
Mometasone—CYP2C8—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	5.25e-05	0.00121	CbGpPWpGaD
Mometasone—Hydrocortisone—NR3C1—type 2 diabetes mellitus	5.21e-05	0.00905	CrCbGaD
Mometasone—Dexamethasone—ABCC2—type 2 diabetes mellitus	5.1e-05	0.00884	CrCbGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	4.95e-05	0.00114	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	4.88e-05	0.00112	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	4.86e-05	0.00112	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—NOTCH2—type 2 diabetes mellitus	4.83e-05	0.00111	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—IL6—type 2 diabetes mellitus	4.79e-05	0.0011	CbGpPWpGaD
Mometasone—Triamcinolone—CYP3A4—type 2 diabetes mellitus	4.73e-05	0.0082	CrCbGaD
Mometasone—Triamcinolone—PTGS2—type 2 diabetes mellitus	4.63e-05	0.00803	CrCbGaD
Mometasone—NR3C1—Gene Expression—NCOA6—type 2 diabetes mellitus	4.6e-05	0.00106	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	4.56e-05	0.00105	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—AR—type 2 diabetes mellitus	4.51e-05	0.00104	CbGpPWpGaD
Mometasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—type 2 diabetes mellitus	4.46e-05	0.00103	CbGpPWpGaD
Mometasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—type 2 diabetes mellitus	4.42e-05	0.00102	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TGFB1—type 2 diabetes mellitus	4.4e-05	0.00101	CbGpPWpGaD
Mometasone—Prednisone—CYP3A4—type 2 diabetes mellitus	4.29e-05	0.00744	CrCbGaD
Mometasone—Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	4.22e-05	0.00733	CrCbGaD
Mometasone—NR3C1—Generic Transcription Pathway—CDKN2B—type 2 diabetes mellitus	4.15e-05	0.000957	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	4.14e-05	0.000954	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	4.14e-05	0.000952	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	4.14e-05	0.000952	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—TNF—type 2 diabetes mellitus	4.11e-05	0.000946	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—BHMT—type 2 diabetes mellitus	4.06e-05	0.000934	CbGpPWpGaD
Mometasone—Prednisolone—CYP3A4—type 2 diabetes mellitus	3.95e-05	0.00686	CrCbGaD
Mometasone—Dexamethasone—NR3C1—type 2 diabetes mellitus	3.88e-05	0.00674	CrCbGaD
Mometasone—Betamethasone—CYP3A4—type 2 diabetes mellitus	3.87e-05	0.00672	CrCbGaD
Mometasone—Betamethasone—PTGS2—type 2 diabetes mellitus	3.79e-05	0.00658	CrCbGaD
Mometasone—Prednisone—ALB—type 2 diabetes mellitus	3.74e-05	0.00649	CrCbGaD
Mometasone—Dexamethasone—CYP2E1—type 2 diabetes mellitus	3.58e-05	0.00621	CrCbGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	3.55e-05	0.000817	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGDS—type 2 diabetes mellitus	3.55e-05	0.000817	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AANAT—type 2 diabetes mellitus	3.55e-05	0.000817	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARA—type 2 diabetes mellitus	3.42e-05	0.000787	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	3.37e-05	0.000776	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CDO1—type 2 diabetes mellitus	3.36e-05	0.000774	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPD2—type 2 diabetes mellitus	3.36e-05	0.000774	CbGpPWpGaD
Mometasone—NR3C1—Adipogenesis—IL6—type 2 diabetes mellitus	3.31e-05	0.000763	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	3.29e-05	0.000757	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	3.27e-05	0.000752	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AK1—type 2 diabetes mellitus	3.21e-05	0.000738	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	3.17e-05	0.00073	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—HNF4A—type 2 diabetes mellitus	3.13e-05	0.000721	CbGpPWpGaD
Mometasone—Hydrocortisone—CYP3A4—type 2 diabetes mellitus	3.02e-05	0.00525	CrCbGaD
Mometasone—CYP2C8—Metabolism—SLC5A4—type 2 diabetes mellitus	2.96e-05	0.000681	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MAT1A—type 2 diabetes mellitus	2.96e-05	0.000681	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	2.95e-05	0.000679	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	2.89e-05	0.000666	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	2.87e-05	0.00066	CbGpPWpGaD
Mometasone—NR3C1—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	2.86e-05	0.00066	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPP1R3C—type 2 diabetes mellitus	2.86e-05	0.000658	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—G6PC—type 2 diabetes mellitus	2.86e-05	0.000658	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HBA2—type 2 diabetes mellitus	2.86e-05	0.000658	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ENPP1—type 2 diabetes mellitus	2.86e-05	0.000658	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ND1—type 2 diabetes mellitus	2.86e-05	0.000658	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—PPARG—type 2 diabetes mellitus	2.82e-05	0.00065	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCGR—type 2 diabetes mellitus	2.77e-05	0.000637	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PSMD6—type 2 diabetes mellitus	2.74e-05	0.00063	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—DNMT1—type 2 diabetes mellitus	2.74e-05	0.00063	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CTGF—type 2 diabetes mellitus	2.69e-05	0.000619	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	2.67e-05	0.000614	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—OXCT1—type 2 diabetes mellitus	2.61e-05	0.000602	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYTB—type 2 diabetes mellitus	2.61e-05	0.000602	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SRD5A1—type 2 diabetes mellitus	2.55e-05	0.000587	CbGpPWpGaD
Mometasone—NR3C1—Generic Transcription Pathway—SERPINE1—type 2 diabetes mellitus	2.54e-05	0.000586	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD17B3—type 2 diabetes mellitus	2.43e-05	0.00056	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—STAR—type 2 diabetes mellitus	2.43e-05	0.00056	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ACACA—type 2 diabetes mellitus	2.43e-05	0.00056	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CBS—type 2 diabetes mellitus	2.33e-05	0.000537	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ABCC8—type 2 diabetes mellitus	2.33e-05	0.000537	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—NOTCH2—type 2 diabetes mellitus	2.33e-05	0.000536	CbGpPWpGaD
Mometasone—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.25e-05	0.00391	CrCbGaD
Mometasone—CYP2C8—Metabolism—COX2—type 2 diabetes mellitus	2.24e-05	0.000516	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC5A2—type 2 diabetes mellitus	2.24e-05	0.000516	CbGpPWpGaD
Mometasone—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.2e-05	0.00383	CrCbGaD
Mometasone—CYP2C8—Metabolism—NCOA6—type 2 diabetes mellitus	2.2e-05	0.000507	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	2.2e-05	0.000507	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AR—type 2 diabetes mellitus	2.17e-05	0.0005	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UCP2—type 2 diabetes mellitus	2.17e-05	0.000499	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD11B1—type 2 diabetes mellitus	2.17e-05	0.000499	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—UCP3—type 2 diabetes mellitus	2.17e-05	0.000499	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	2.1e-05	0.000484	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PCK1—type 2 diabetes mellitus	2.04e-05	0.000469	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	2.01e-05	0.000462	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—CDKN2B—type 2 diabetes mellitus	2e-05	0.000461	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SIRT1—type 2 diabetes mellitus	1.98e-05	0.000456	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1.96e-05	0.00045	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HK1—type 2 diabetes mellitus	1.91e-05	0.000439	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	1.91e-05	0.000439	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HSD3B2—type 2 diabetes mellitus	1.84e-05	0.000424	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPA—type 2 diabetes mellitus	1.84e-05	0.000424	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCKR—type 2 diabetes mellitus	1.84e-05	0.000424	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—KCNJ11—type 2 diabetes mellitus	1.84e-05	0.000424	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	1.77e-05	0.000408	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALDOB—type 2 diabetes mellitus	1.77e-05	0.000407	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	1.75e-05	0.000402	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	1.72e-05	0.000395	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	1.68e-05	0.000387	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	1.66e-05	0.000383	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	1.65e-05	0.000379	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GLP1R—type 2 diabetes mellitus	1.64e-05	0.000378	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A2—type 2 diabetes mellitus	1.53e-05	0.000353	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTR—type 2 diabetes mellitus	1.5e-05	0.000346	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CPT1A—type 2 diabetes mellitus	1.5e-05	0.000346	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NAMPT—type 2 diabetes mellitus	1.47e-05	0.000339	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	1.46e-05	0.000337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HBA1—type 2 diabetes mellitus	1.46e-05	0.000337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LIPC—type 2 diabetes mellitus	1.46e-05	0.000337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCK—type 2 diabetes mellitus	1.46e-05	0.000337	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP11A1—type 2 diabetes mellitus	1.45e-05	0.000335	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC9A1—type 2 diabetes mellitus	1.43e-05	0.000329	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CETP—type 2 diabetes mellitus	1.41e-05	0.000325	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	1.36e-05	0.000313	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	1.32e-05	0.000303	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PSMD6—type 2 diabetes mellitus	1.31e-05	0.000302	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SREBF1—type 2 diabetes mellitus	1.31e-05	0.000302	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SNAP25—type 2 diabetes mellitus	1.31e-05	0.000302	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CTGF—type 2 diabetes mellitus	1.29e-05	0.000297	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMGCR—type 2 diabetes mellitus	1.28e-05	0.000294	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	1.26e-05	0.00029	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADRA2A—type 2 diabetes mellitus	1.25e-05	0.000288	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	1.22e-05	0.000282	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP2E1—type 2 diabetes mellitus	1.2e-05	0.000276	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A1—type 2 diabetes mellitus	1.19e-05	0.000273	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP1A2—type 2 diabetes mellitus	1.19e-05	0.000273	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	1.16e-05	0.000267	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.15e-05	0.000265	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	1.14e-05	0.000262	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	1.14e-05	0.000262	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	9.81e-06	0.000226	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	9.81e-06	0.000226	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	9.76e-06	0.000225	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	9.63e-06	0.000222	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	9.35e-06	0.000215	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	9.1e-06	0.000209	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	8.93e-06	0.000206	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	8.74e-06	0.000201	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	8.71e-06	0.000201	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	8.48e-06	0.000195	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	8.38e-06	0.000193	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	8.04e-06	0.000185	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	7.89e-06	0.000182	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	7.64e-06	0.000176	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	7.51e-06	0.000173	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	7.48e-06	0.000172	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	7.4e-06	0.00017	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	6.52e-06	0.00015	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	6.39e-06	0.000147	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	5.86e-06	0.000135	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	5.61e-06	0.000129	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	5.61e-06	0.000129	CbGpPWpGaD
Mometasone—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	5.38e-06	0.000124	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	5.13e-06	0.000118	CbGpPWpGaD
Mometasone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	2.58e-06	5.94e-05	CbGpPWpGaD
